beta

AERI

Aerie Pharmaceuticals Inc.

Aeri

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is engaged in the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.

Market Cap: 2.17 Billion

Primary Exchange: NASDAQ Global Market

Website: http://www.aeriepharma.com

Shares Outstanding: 38 Million

Float: 37.2 Million

Dividend: 0.0 (0.0%)

Beta: 0.0

Sector: Healthcare

Industry: Drug Manufacturers

Short Interest (Jan 12, 2018): 3.95 Million

Ethical Flags

Animal testing

Longest drawdown: 435 trading days

From: 2018-07-19 To: 2019-10-11

Lowest Point:

Aerie Pharmaceuticals to Present at Two Upcoming Investor Conferences

via: Business Wire at 2019-06-11 03:30:00:000

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye today announced that … read more...

Aerie Pharmaceuticals to Present at Two Upcoming Investor Conferences

via: Business Wire at 2019-06-11 03:30:00:000

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye today announced that … read more...

Aerie Pharmaceuticals to Present at Two Upcoming Investor Conferences

via: Business Wire at 2019-06-11 03:30:00:000

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye today announced that … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud